Showing results (21-30 of 114) with videos related to
Sort By:
Pageof 12
Science Signaling|August 12, 2010
B cell receptor signaling: picky about PI3KsJose J Limon, David A FrumanSeminars in Cell & Developmental Biology|June 24, 2004
PI3K signaling controls cell fate at many points in B lymphocyte development and activationAmber C Donahue, David A FrumanSeminars in Immunology|March 9, 2002
Phosphoinositide 3-kinase in immunological systemsDavid A Fruman, Lewis C CantleyThe Biochemical Journal|May 10, 2008
Cancer therapy: staying current with AMPKDavid A Fruman, Aimee L EdingerAnnual Review of Immunology|March 23, 2004
Phosphoinositide 3-kinase: diverse roles in immune cell activationJonathan A Deane, David A FrumanJournal of Immunology (Baltimore, Md. : 1950)|June 10, 2003
Proliferation and survival of activated B cells requires sustained antigen receptor engagement and phosphoinositide 3-kinase activationAmber C Donahue, David A FrumanEuropean Journal of Immunology|August 29, 2007
Distinct signaling mechanisms activate the target of rapamycin in response to different B-cell stimuliAmber C Donahue, David A FrumanCancer Research|March 23, 2005
ABL oncogenes and phosphoinositide 3-kinase: mechanism of activation and downstream effectorsMichael G Kharas, David A FrumanThe Journal of Clinical Investigation|August 19, 2014
Too much of a good thing: immunodeficiency due to hyperactive PI3K signalingCraig M Walsh, David A FrumanFrontiers in Immunology|August 14, 2012
Akt and mTOR in B Cell Activation and DifferentiationJose J Limon, David A FrumanPageof 12